Surgery Partners, Inc.（股票代码：SGRY）今日盘后股价大幅上涨7.15%，引起了市场的广泛关注。
消息面上，该公司重申了对2026财年的财务预期，确认全年总收入指导范围仍为33.5亿美元至34.5亿美元，同时经调整的息税折旧及摊销前利润（Adj EBITDA）预计将至少达到5.3亿美元。这一举措展现了管理层对业务增长轨迹和盈利能力的信心，有效增强了投资者的乐观情绪。
在医疗保健行业持续演变的背景下，清晰的财务指引有助于投资者评估公司的运营韧性和未来价值，这被认为是推动股价在盘后时段显著上涨的主要因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.